Completed PHASE4 INTERVENTIONAL NCT00161070

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Sponsor: UMC Utrecht

Conditions Arteriosclerosis Brain Ischemia Transient Ischemic Attack

Interventions anticoagulation aspirin alone aspirin and dipyridamole

Updated 5 times since 2017 Last updated: Mar 21, 2007 Started: Jul 31, 1997 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Arteriosclerosis and Brain Ischemia and is currently completed. UMC Utrecht leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UMC Utrecht

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands